Business
Why the Nova Eye (ASX:EYE) share price is surging 7% higher
The Nova Eye Medical Ltd (ASX: EYE) share price is in the green today. This comes after the company released positive results showing the efficacy of its 2RT treatment.
During mid-afternoon trade, the medical technology company’s shares are up 7.58% to 36 cents.
What were the results?
In today’s release, Nova Eye advised that it has published the results of its 5-year patient follow-up data from the LEAD trial in a recent publication of Ophthalmology Retina. The article discusses the long-term effect of subthreshold nanosecond laser (SNL) treatment on progression to late age-related macular degeneration (AMD).
The company said the LEAD trial…
-
Noosa News17 hours agoAustralia Zoo reunites with the Ukrainian community
-
Noosa News17 hours ago“Hidden gem”: last chance for renovated bayside homes below $1m
-
General21 hours agoWimbledon men’s final, Jannik Sinner vs Carlos Alcaraz live updates — blog, scores and stats
-
Business14 hours agoThe pros and cons of buying Accent shares after its decline